SAN FRANCISCO (KGO) -- There's been an important medical development in what doctors are calling a turning point in the fight against hepatitis C, a terrible disease that can lead to liver failure. The FDA has just approved a new medicine that could be a major step forward.
Rene Pefley has been battling the effects of hepatitis C for more than a decade. "It's hard, it's tough, it's rough going through it. It makes you very tired," he says.
After having her condition relapse following previous treatments, she enrolled in a clinical trial for a drug soon to marketed under the name Incivek. Her doctor, Natalie Bzowej of the California Pacific Medical Center, says the stakes are high given that hepatitis C is a leading cause of liver transplants.
Continue reading........
No comments:
Post a Comment